Thursday, July 19, 2012

2012 ADDF/ LBDA Lewy Body Dementia Biomarker Research Award

2012 ADDF/ LBDA Lewy Body Dementia Biomarker Research Award 
The Alzheimer’s Drug Discovery Foundation (ADDF) and The Lewy Body Dementia Association (LBDA) are issuing a Request for Proposals for the 2012 ADDF/LBDA Lewy Body Dementia Biomarker Research Award. This award will provide selected programs with up to $100,000 for one year of support to catalyze a research project focused on developing innovative biomarkers that aid in early diagnosis, detection and disease monitoring of Lewy Body Dementia. Applications may be submitted by non-profit academic institutions and for-profit biotechnology companies, both public and private, worldwide. 
Interested applicants must first submit a Letter of Intent electronically via the ADDF website (, deadline September 26th, 2012. Deadline for complete applications is October 10th, 2012. Applications will be confidentially reviewed by the ADDF and an external Scientific Review Committee including members of LBDA Scientific Advisory Council. Applications from biotechnology companies will be additionally reviewed by ADDF’s external Business Advisory Board and awarded as a Program Related Investment. The award recipient will be publicly announced in Spring 2013
ADDF and LBDA seek to work with prospective applicants to ensure appropriate and qualified programs of interest that meet their partnership objectives. An inquiry with ADDF scientific staff is therefore encouraged prior to application submission. More information can also be found on the ADDF website ( 
To further discuss scientific aspects of proposals, please contact: 
Diana Shineman, PhD 
Assistant Director for Scientific Affairs 
Phone: 212-901-8007 
For more information regarding the application process, please contact: 
Niyati Thakker 
Grants Associate Phone: 212-901-8019 
To learn more about the Lewy Body Dementia Association, visit

No comments:

Post a Comment